Why Partner with Us
Who We Are
Asahi Kasei Pharma Corporation is an R&D-based pharmaceutical company headquartered in Tokyo, Japan, specializing in the therapeutic areas of pain management, musculoskeletal disorders, autoimmune diseases, critical care medicine, and rare diseases.
Proven Record of Successful Partnerships
We have successfully partnered with large and small organizations to develop and commercialize a variety of innovative treatments including Famvir® (famciclovir), Flivas™ (naftopidil), Toledomin™ (milnacipran hydrochloride), Xiaflex® (collagenase clostridium histolyticum), Reclast® (zoledronic acid), and Kevzara® (sarilumab).
Commercial Access in Japan, East Asia, and the U.S.
Asahi Kasei Pharma fields an experienced, nationwide sales force in Japan.
Recently, Veloxis Pharmaceuticals, a U.S.-based specialty pharmaceutical company committed to improving the lives of transplant patients, has joined Asahi Kasei Group, enabling us to establish a U.S. commercial foundation.
We also have commercial access to other pharmaceutical markets in East Asia through our China subsidiary, Asahi Kasei Pharma Beijing, as well as partners in China, Korea, and Taiwan.
Clinical Development/Regulatory Affairs Management in Japan, China, and Worldwide
We have a well-established record of managing clinical trials and successfully obtaining product marketing approvals in Japan.
We manage our clinical development activities and regulatory submissions in China through our subsidiary, Asahi Kasei Pharma (Beijing) Co., Ltd..
We manage our global clinical development activities and regulatory submissions outside of Japan and China through our U.S. subsidiary, Asahi Kasei Pharma America, located near Boston, Massachusetts.
We discover and conduct preclinical testing of new drug compounds at our research campus near Tokyo, Japan, using proven drug discovery techniques and cutting-edge technologies.
We have a strong history of discovering innovative medicines that has led to development and marketing of our products, such as Teribone®, Recomodulin®, etc.